Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma

AIDS

Volumn 12, Issue 7, 1998, Pages

  Lebbé, Céleste ^a   Blum, Laurent ^b   Pellet, Claire ^a   Blanchard, Geneviève ^b   Vérola, Olivier ^a   Morel, Patrice ^a   Danne, Odile ^b   Calvo, Fabien ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE HOSPITALIER RENÉ DUBOS   (France)

Author keywords

Antiretroviral therapy; HIV associated Kaposi's sarcoma; Human herpesvirus type 8

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; LAMIVUDINE; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIREMIA; VIRUS LOAD;

EID: 0032492955     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199807000-00002     Document Type: Article

References (21)

1. Lyter DW, Bryant R, Thackeray R, Rinaldo CR, Kingsley LA: Incidence of human immunodeficiency virus-related and non-related malignancies in a large cohort of homosexual men. J Clin Oncol 1995, 13:2540-2546.
2. Blasig C, Zietz C, Haar B, et al.: Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997, 71:7963-7968.
3. Boshoff C, Schulz T, Kennedy M, et al.: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995, 1:1274-1278.
4. Moore PS, Kingsley LA, Holmberg SD, et al.: Kaposi's sarcoma-associated herpesvirus infection prior to the onset of Kaposi's sarcoma. AIDS 1996, 10:175-180.
5. Whitby D, Howard MM, Tenant-Flowers M, et al.: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799-802.
6. Ambroziak JA, Blackbourn DJ, Herndier BG, et al.: Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients [letter]. Science 1995, 268:582-583.
7. Lebbé C, Agbalika F, De Crémoux P, et al.: Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi's sarcoma. Arch Dermatol 1997, 133:25-30.
8. Brambilla L, Boneschi V, Berti E, Corbellino M, Parravicini C: HHV8 cell-associated viraemia and clinical presentation of Mediterranean Kaposi's sarcoma [letter]. Lancet 1996, 347:1338.
9. Lilenbaum RC, Ratner L: Systemic treatment of Kaposi's sarcoma: current status and future directions. AIDS 1994, 8:141-151.
10. McDonald C, Kuritkes D: Human immunodeficiency virus type 1 protease inhibitors. Arch Intem Med 1997, 157:951-959.
11. Murphy M, Armstrong D, Sepkowitz KA, Ahkami RN, Myskowski PL: Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor [letter]. AIDS 1997, 11:261-262.
12. Blum L, Pellet C, Agbalika F, et al.: Complete remission of AIDS-related Kaposi's sarcoma associated with human herpesvirus-8 sequences during anti-HIV protease therapy [letter]. AIDS 1997, 11:1653-1655.
13. Conant MA, Opp KM, Poretz D, Mills RG: Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir [letter]. AIDS 1997, 11:1300-1301.
14. Burdick AE, Carmichael C, Rady PL, Tyring SK, Badiavas E: Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus-8 DNA in a patient with AIDS after protease inhibitor therapy [letter]. J Am Acad Dermatol 1997, 37:648-649.
15. Krown S, Metroka C, Wernz J: Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 1989, 7:1201-1207.
16. Chang Y, Cesarman E, Pessin M, et al.: Identification on a new human herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
17. Dupin N, Grandadam M, Calvez V, et al.: Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995, 345:761-762.
18. Bigoni B, Dolcetti R, De Lellis L, et al.: HHV8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996, 173:542-549.
19. Autran B, Carcelain G, Li T, et al.: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
20. Ensoli B, Gendelman R, Markham P, et al.: Synergy between fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 371:674-680.
21. Harrington W Jr, Sieczkowski L, Sosa C, et al.: Activation of HHV-8 by HIV-1 tat [letter]. Lancet 1997, 349:774-775.